Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project.

MLA

Balayssac, David, et al. “Neurofilament Light Chain in Plasma as a Sensitive Diagnostic Biomarker of Peripheral Neurotoxicity: In Vivo Mouse Studies with Oxaliplatin and Paclitaxel - NeuroDeRisk Project.” Biomedicine & Pharmacotherapy, vol. 167, Nov. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.115535.

APA

Balayssac, D., Busserolles, J., Broto, C., Dalbos, C., Prival, L., Lamoine, S., Richard, D., Quintana, M., Herbet, A., Hilairet, S., Hu, Y., Loryan, I., Glaab, W. E., Micheli, L., Ghelardini, C., Di Cesare Mannelli, L., Perrault, O., & Slaoui, M. (2023). Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project. Biomedicine & Pharmacotherapy, 167, N.PAG. https://doi.org/10.1016/j.biopha.2023.115535

Chicago

Balayssac, David, Jérôme Busserolles, Catherine Broto, Cristelle Dalbos, Laetitia Prival, Sylvain Lamoine, Damien Richard, et al. 2023. “Neurofilament Light Chain in Plasma as a Sensitive Diagnostic Biomarker of Peripheral Neurotoxicity: In Vivo Mouse Studies with Oxaliplatin and Paclitaxel - NeuroDeRisk Project.” Biomedicine & Pharmacotherapy 167 (November): N.PAG. doi:10.1016/j.biopha.2023.115535.